Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250353) titled 'Veltassa 8.4 g powder for suspension post-marketing surveillance study' on Sept. 10.
Study Type: Observational
Study Design:
single arm study, open(masking not used), uncontrolled control, single assignment, other
Primary Sponsor: Kasahara Masaaki
Condition:
Hyperkalemia
potassium
D006947
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 01/04/2026
Target Sample Size: 450
To know more, visit https://jrct.mhlw.go.jp/latest-detail/jRCT2031250353
Published by HT Digital Content Services with permission from Health Daily Digest....